Dewpoint Therapeutics Announces DPTX3496 as a Development Candidate for the Treatment of Colorectal, Breast, and Lung Cancers
January 29, 2025 08:00 ET
|
Dewpoint Therapeutics
Dewpoint Therapeutics’ second development candidate, DPTX3496 is an oral, small molecule acting via a novel condensate-modulating mechanism of action for the treatment of Wnt-driven cancersDPTX3496...
aTyr Pharma to Present Three Posters for Efzofitimod at the American Thoracic Society (ATS) 2025 International Conference
January 29, 2025 08:00 ET
|
aTyr Pharma, Inc.
Blinded baseline demographics and disease characteristics for ongoing Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis; topline data from the study expected in the third quarter of 2025...
Refined Energy Corp. Details Proposed Summer Program for Basin and Milner Projects
January 29, 2025 08:00 ET
|
Refined Energy Corp.
VANCOUVER, British Columbia, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Refined Energy Corp. (CSE: RUU; OTC: RFMCF; FRA: CWA0) (“Refined” or the “Company”) is pleased to provide details of a proposed summer...
Scality launches Cloud & Service Provider Program with Pay-as-you-Go licensing for Veeam Partner Ecosystem
January 29, 2025 08:00 ET
|
Scality
SAN FRANCISCO, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Scality, a global leader in cyber-resilient storage software for the AI era, today announced the launch of its Pay-as-you-Go licensing model for...
Enviri Corporation Announces Timing of Fourth Quarter and Full Year 2024 Results and Conference Call
January 29, 2025 08:00 ET
|
Enviri
PHILADELPHIA, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Enviri Corporation (NYSE: NVRI) today announced that it will issue its fourth quarter and full year 2024 earnings results on Thursday, February 20,...
Stirista Expands Marketing Technology Suite with Strategic Acquisitions of Magnetik and Andrews Wharton
January 29, 2025 08:00 ET
|
Stirista
San Antonio, TX, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Stirista, a leader in data-driven marketing innovation, has announced the acquisitions of Magnetik and Andrews Wharton, companies known for their...
Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on February 5
January 29, 2025 08:00 ET
|
Calidi Biotherapeutics, Inc
SAN DIEGO, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor...
Premier Health Announces Travel Nurse Contingent Labour Master Agreement with Nova Scotia Health Authority
January 29, 2025 08:00 ET
|
Premier Health of America Inc.
Premier Health signs contingent agreement with Nova Scotia Health Authority
CervoMed to Present at the 8th International Lewy Body Dementia Conference
January 29, 2025 08:00 ET
|
CervoMed Inc.
BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that topline...
ZJK Industrial Group Hosts Grand Year-End Celebration to Unite Employees and Stakeholders for a Glorious Future
January 29, 2025 08:00 ET
|
ZJK Industrial Co., Ltd.
Shenzhen, China, Jan. 29, 2025 (GLOBE NEWSWIRE) -- ZJK Industrial Co. Ltd. (NASDAQ: ZJK) (“ZJK Industrial” or the “Company”), a high-tech precision parts and hardware manufacturer for artificial...
- January 31, 2025 16:57 ET SQ Stockholders with Large losses Should Contact Shareholder Rights Law Firm Robbins LLP for Information About the Block, Inc. Class Action
- January 31, 2025 16:57 ET Swing Into Action: The RMG Super Celebrity Shootout Returns for Year Two